A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension

To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis

NCT06296095 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function

NCT06093230 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

NCT02462967 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic Impairment

NCT00672581 ·Status: COMPLETED ·Phase: PHASE1

Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

NCT03479125 ·Status: TERMINATED

Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices

NCT02508623 ·Status: UNKNOWN ·Phase: PHASE3

Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease

NCT06825559 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

NCT06750276 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.

NCT05857644 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension

NCT00594191 ·Status: COMPLETED ·Phase: PHASE2

Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial

NCT06629909 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases

NCT06891365 ·Status: RECRUITING ·Phase: PHASE1

Cardiox Liver Function Test Pivotal Trial

NCT02552901 ·Status: WITHDRAWN ·Phase: PHASE3

A Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HCL001 Cell Injection (Homologous Allogeneic Hepatocytes) in Patients With Decompensated Cirrhosis

NCT06306781 ·Status: NOT_YET_RECRUITING ·Phase: NA

Pentoxifylline Plus Carvedilol vs Carvedilol Monotherapy in Preventing New Decompensation in Stable Cirrhotic Patients With Prior Decompensation

NCT06041932 ·Status: UNKNOWN ·Phase: NA

Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment

NCT02865369 ·Status: UNKNOWN

6-week Safety and PD Study in Adults With NAFLD

NCT03256526 ·Status: COMPLETED ·Phase: PHASE2

A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

NCT07229911 ·Status: RECRUITING ·Phase: PHASE1

A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis

NCT06671275 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease

NCT05045482 ·Status: RECRUITING ·Phase: PHASE1

Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites

NCT01349335 ·Status: COMPLETED ·Phase: PHASE2

Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C

NCT00930995 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy

NCT00999167 ·Status: COMPLETED ·Phase: PHASE2

Intrahepatic Reinfusion of CD133+ Stem Cells in Cirrhotic Patients

NCT01025622 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Effect of Hepatic Impairment on JNJ-56136379

NCT04208399 ·Status: COMPLETED ·Phase: PHASE1